Ryvu and TIM to enter Warsaw’s mWIG40 index

WARSAW (Reuters) – Pharmaceutical company Ryvu Therapeutics and distributor of electrotechnical products TIM will enter Warsaw’s mWIG40 index effective after market close on Sept. 15, the bourse said on Thursday.

Their shares will replace BNP Paribas Bank Polska and biotechnology company Mabion in the index.

There will be no changes to Warsaw’s index of the 20 biggest and most liquid companies WIG20, the bourse also said.

(Reporting by Anna Koper; editing by Mark Heinrich)